Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year
SCC066, Merck Millipore) with the Omega RNA Isolation Kit (cat
What it does not do, in the published animal data, is push the growth-hormone side of the molecule
Zepbound vs Wegovy side effects Both Zepbound and Wegovy can cause gastrointestinal side effects, such as nausea, diarrhea, and vomiting, which are the most common side effects
Most plans cover Ozempic when prescribed for diabetes, but it wont be covered for off-label weight loss
Potential Side Effects and Precautions Minimal Side Effects While B12 shots are generally well-tolerated, its essential to be aware of potential side effects